Agnese Proietti

Association of BRAF V600E Mutation with Poor Clinicopathological Outcomes in 500 Consecutive Cases of Papillary Thyroid Carcinoma

Cristiana Lupi, Riccardo Giannini, Clara Ugolini et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 393 citations · Full text

Crizotinib in <i>MET</i> -Deregulated or <i>ROS1</i> -Rearranged Pretreated Non–Small Cell Lung Cancer (METROS): A Phase II, Prospective, Multicenter, Two-Arms Trial

Lorenza Landi, Rita Chiari, Marcello Tiseo et al. · Clinical Cancer Research · 2019 · 183 citations · Full text

The Heterogeneous Distribution of BRAF Mutation Supports the Independent Clonal Origin of Distinct Tumor Foci in Multifocal Papillary Thyroid Carcinoma

Riccardo Giannini, Clara Ugolini, Cristiana Lupi et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 107 citations · Full text

Lymphocyte and Immature Dendritic Cell Infiltrates in Differentiated, Poorly Differentiated, and Undifferentiated Thyroid Carcinoma

Clara Ugolini, Fulvio Basolo, Agnese Proietti et al. · Thyroid · 2007 · 89 citations

<i>ALK</i> Rearrangement in a Large Series of Consecutive Non–Small Cell Lung Cancers: Comparison Between a New Immunohistochemical Approach and Fluorescence In Situ Hybridization for the Screening of Patients Eligible for Crizotinib Treatment

Greta Alì, Agnese Proietti, S Pelliccioni et al. · Archives of Pathology & Laboratory Medicine · 2014 · 87 citations